Oragenics Inc
Pharmaceutical company · Lakewood Ranch, Florida, United States · NYSE: OGEN
Oragenics Inc is a pharmaceutical company headquartered in Lakewood Ranch, Florida, United States. Its shares trade on NYSE under the ticker OGEN. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $456,654 in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $850,000 sold in a notice filed in 2023.
Oragenics at a glance
What does Oragenics do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $456,654 in total (2004 to 2021). NIH funding came from the National Institute of General Medical Sciences.
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $850,000 sold (2023).
Frequently asked questions about Oragenics
Where is Oragenics headquartered?
Oragenics Inc is headquartered in Lakewood Ranch, Florida, United States.
What does Oragenics do?
Oragenics Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Oragenics a public company?
Yes. Oragenics Inc trades on NYSE under the ticker OGEN.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.